medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2020, Number 3

<< Back Next >>

Alerg Asma Inmunol Pediatr 2020; 29 (3)

Determination of environmental pollutants and relation of the pediatric patient with asthma status

Abreu PD, Montero ?L, Sánchez RS?, Sánchez ??M, Martín PNI

Language: Spanish
References: 38
Page: 93-98
PDF size: 201.26 Kb.


ABSTRACT

Introduction: Bronchial asthma (AB) is the most frequent chronic respiratory disease in the world. There are multiple factors involved in its recurrence such as environmental pollutants. Objective: Determination of the environmental factors involved in the increase in the severity and frequency of the state of asthmatic disease in the child. Material and methods: A descriptive study of all children between 5 and 18 years old who entered the pediatric intensive care unit (PICU) for an asthmatic state between January 2010 and January 2019 was carried out. Results: The sample is of 27 patients aged 5-17 years. Children of 5-11 years, male, predominate in the pollutants, 100% are exposed to cigarette smoke or tobacco a day and 15 children, in their homes they cooked with firewood, coal or oil (55.56%). Symptoms are triggered with exposure between 3-6 months in 18 patients (66.67%). There is a relationship between respiratory work with decreased SaO2 (below 80%) and hypoxemia in gasometry (PaO2 between 41 and 55 mmHg) in 12 of the patients at admission. They are managed with standard treatment with inhaled beta 2 agonists, IV steroids and methylxanthines in 100% series. The average stay of 7.26 days. Conclusions: The presence of environmental pollutants may be a factor that predisposes to the appearance of episodes of asthmatic status in the pediatric patient.


REFERENCES

  1. Guía Mexicana del Asma 2017. Neumología y Cirugía del Tórax. 2017; 76 (1): ISSN 0028-3746.

  2. Álvarez GE, Barchilón CV, Casas MF, Entrenas CL, Fernández RJ, García de Vinuesa BG et al. Documento de Consenso sobre Asma Bronquial en Andalucía. Elaborado por Neumosur, Samfyc y Semergen-Andalucía. Rev Español Patol Torácica. 2009; 21 (4): 201-235.

  3. Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004; 59 (5): 469-478.

  4. Erazo CHA, Paucar MMG. Factores ambientales y su influencia en el asma bronquial en niños de 4-6 años en la parroquia 7 de octubre Cantón Quevedo los Ríos primer semestre 2018 (tesis). Los Ríos, Ecuador, Universidad Técnica de Babahoyo; 2018.

  5. Erazo RLM, Montero CM. Factores de riesgo y su relación con las infecciones respiratorias altas en niños menores de 5 años comunidad San Agustín cantón Babahoyo, Los Ríos periodo de septiembre 2017 a febrero de 2018 (tesis). Los Ríos, Ecuador, Universidad Técnica de Babahoyo; 2018.

  6. Montes MJ. Asma grave en pediatría. Hospital de niños de la Santísima Trinidad, Córdova. En: 38 Congreso Argentino de Pediatría, Buenos Aires, 26-29 sept 2017. Argentina 2017. Disponible en: www.sap.org.ar.

  7. Quijano VM. Efectos de las técnicas manuales de fisioterapia respiratoria durante la intercrisis asmática de niños del Hospital Central de la Policía Nacional del Perú (tesis) Lima, Universidad Peruana Cayetano Heredia; 2019.

  8. Anuario Estadístico de Salud, Ministerio de salud pública. Dirección de registros médicos y estadística de salud. La Habana 2017. ISSN 1561-4433.

  9. Orraca CO, Orraca CM, Lardoeyt FR, Quintero PR. Factores genéticos del asma bronquial en pacientes con edad pediátricos en Pinar del Río. Rev Cienc Med Pinar Río. 2017; 21 (3): 305-311. On line ISSN 1561-3194.

  10. Manejo ambiental del asma pediátrica. Guías para el personal de salud. National Environmental Education Foundation, Washington DC, 2005. Available in: http://www.neefusa.org/health/asthma/asthma_resources.htm.

  11. Romero PM, Diego OF, Álvarez TM. La contaminación del aire: su repercusión como problema de salud. Rev Cubana Hig Epidemiol. 2006; 44 (2): 1-14.

  12. Romero-Placeres M, Más-Bermejo P, Lacasaña-Navarro M, Téllez Rojo-Solís MM, Aguilar-Valdés J, Romieu I. Contaminación atmosférica, asma bronquial e infecciones respiratorias agudas en menores de edad de La Habana. Sal Publ Mex. 2004; 46: 222-223.

  13. González AA, Horta RF. Ozono, contaminación ambiental y la medicina basada en evidencias. Rev Cub Fis. 2017; 34 (1): 70-79.

  14. Sánchez EJ, Mintegri RS. Crisis asmática. Urgencias de Pediatría, Hospital de Cruces, Bizkaia. En: Protocolo de diagnóstico-terapéutica de urgencias pediátricas. Sociedad Española de Urgencias Pediátricas.

  15. Molina E, Meneses E. Evaluación epidemiológica del impacto de los contaminantes del aire. Propuesta metodológica. Rev Cubana Hig Epidemiol. 2003; 41 (2-3).

  16. Giubergia V, Ramírez FMJ, Pérez V, González A, Crespi N, Fridman N et al. Severe asthma in pediatrics: outcomes of the implementation of a special health care protocol. Arch Argent Pediatr. 2018; 116 (2): 105-111. doi: 10.5546/aap.2018.eng.105.

  17. Fishe JN, Palmer E, Finlay E, Smotherman C, Gautam S, Hendry P et al. A statewide study of the epidemiology of emergency medical services’ management of pediatric asthma. Pediatr Emerg Care. 2019. doi: 10.1097/PEC0000000000001743.

  18. Lammers N, Van Hoesel MHT, Kamphuis M, Brusse-Keizer M, Van der Palen J, Visser R. Assessing exercise-induced bronchoconstriction in children; the need for testing. Front Pediatr. 2019; 7: 157. doi: 10.3389/fped.2019.00157.

  19. Ballardini N, Kramer MS, Oken E, Henderson AJ, Bogdanovich N, Dahhou M. Associations of atopic dermatitis and asthma with child behaviour: results from the PROBIT cohort. Clin Exp Allergy. 2019; 49 (9): 1235-1244. doi: 10.1111/cea.13417.

  20. Álvarez CM, Docando DN, Álvarez AA, Dotres MC, Baños TD, Sardiñas AM. Comportamiento del asma bronquial en un Área de salud del policlínico Cerro. Rev Cubana Med Gen Integr. 2011; 27 (1): 50-62. On Line/ISSN 0864-2125.

  21. Khamis IN, Alhainiah M, Khayat M, Orjwan AO, Almaghrabi S, Felmban O. Quality of life of asthmatic children and their caregivers. Pak J Med Sci. 2019; 35(2): 521-526.

  22. Munayco CV, Arana J, Torres CJ, Sarabia L, Soto CG. Prevalencia y factores asociados al asma en niños de 5 a 14 años de un área rural del sur de Perú. Rev Peru Med Exp Salud Publica. 2009; 26 (3): 307-313.

  23. Jiménez FL, Fernández ML, Sarmiento BG, González GV, Martin RL. Comportamiento del Asma Bronquial en la edad pediátrica. Rev Cubana Med Gen Integr. 2001; 17 (1): 43-49. On-line/ISSN 1561-3038.

  24. Guilbert TW, LB Bacharier LB, AM Fitzpatrick AM. Severe asthma in children. J Allergy Clin Inmunol Pract. 2014; 2 (25): 489-500.

  25. Rincón SJ. Correlación de los índices de PaO2/FiO2 y SaO2/FiO2 en el postoperatorio de la cirugía cardiaca en una Unidad de Terapia Postquirúrgica Cardiovascular. Med Crit. 2013; 27 (2): 71-76.

  26. Ozer M, Buyuktiryaki B, Sahiner UM, Teksam O, Karaatmaca B, Soyer O et al. Repeated doses of salbutamol and aeroallergen sensitisation both increased salbutamol-induced hypoxia in children and adolescents with acute asthma. Acta Paediatr. 2018; 107 (4): 647-652.

  27. Stefan MS, Nathanson BH, Lagu T, Priya A, Pekow PS, Steingrub JS. Outcomes of noninvasive and invasive ventilation in patients hospitalized with asthma exacerbation. Am An Thorac Soc. 2016; 13 (7): 1096-1104.

  28. Hom KLE, Leung AKC. Medications and recent patents for status asthmaticus in children. Recent Pat Inflamm Allergy Drug Discov. 2017; 11 (1): 12-21.

  29. Oliva OA, Mikrogianakis A. Managing the paediatric patient with an acute asthma exacerbation. Paediatr Child Health. 2012; 17 (5): 251-256.

  30. GINA. Dificult to treat & severe asthma in adolescent and adult patients. Diagnostic and management. A GINA pocket guide for healt profesional. November 2018.

  31. Knightly R, Milan SJ, Hugdes R, Knopp-Sihota JA, Rowe BH, Powell C et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2017; (11): CD003898.

  32. Kew KM, Kirtchuk L, Michell CL. Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department. Cochrane Database Syst Rev, 2014; 28 (5): CD010909.

  33. Jat KR, Chawla D. Ketamine for management of acute exacerbations of asthma in children. Cochrane Database Syst Rev. 2012; 11: CD009293.

  34. Allen JY, Macías CG. The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. Ann Emerg. 2005; 46 (1): 43-50.

  35. Verscheure PF. Estado asmático en pediatría. Neumol Pediatr. 2016; 11 (4): 155-161.

  36. Beghi G, De Tanti A, Serafini P, Bertolino C, Celentano A, Taormina G. Monitoring of hospital acquired pneumonia in patients with severe brain injury on first access to intensive neurological rehabilitation: first year of observation. Monaldi Arch Chest Dis. 2018; 88 (1): 888. doi: 10.4081/monaldi.2018.888.

  37. Comerlato PH, Rebelatto TF, Santiago de Almeida FA, Klein LB, Boniatti MM, Schaan BD. Complications of central venous catheter insertion in a teaching hospital. Rev Assoc Med Bras. 2017; 63 (7): 613-620. doi: 10.1590/1806-9282.63.07.613.

  38. Lourido CT, Váldez CL, González-Barcada FJ. Hospitalizaciones por asma. Asma 2017; 2 (3): 197-206.




2020     |     www.medigraphic.com